Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.215 EUR | -87.75% | -87.28% | -80.28% |
06-28 | GeNeuro: failure of phase 2 study in Covid long | CF |
06-28 | GeNeuro Announces Results of the Gnc-501 Study in Post-Covid-19 Syndrome | CI |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
6.82M | - | - | - | - | - | |
45.51B | - | |||||
39.36B | ||||||
38.52B | ||||||
30.74B | - | |||||
26.03B |
- Stock Market
- Equities
- GNRO Stock
- Charts GeNeuro SA
- Sector Chart